Clinical Characteristics and Histologic Features of Hysterectomy Specimens From Transmasculine Individuals

被引:15
作者
Cao, Connie D.
Amero, Molly A.
Marcinkowski, Katrina A.
Rosenblum, Norman G.
Chan, Joanna S. Y.
Richard, Scott D. [1 ]
机构
[1] Thomas Jefferson Univ Hosp, Dept Obstet & Gynecol, Div Gynecol Oncol, Philadelphia, PA 19107 USA
关键词
TO-MALE PATIENTS; OVARIAN CONSERVATION; TESTOSTERONE; OOPHORECTOMY; POPULATION; GUIDELINES; BREAST;
D O I
10.1097/AOG.0000000000004421
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: To describe the clinical characteristics of transmasculine individuals who underwent hysterectomy and characterize surgical pathology findings. METHODS: Under an institutional review board-approved protocol, transmasculine individuals who were undergoing hysterectomy and bilateral salpingectomy or bilateral salpingo-oophorectomy were retrospectively identified from a single institution. Past medical, surgical, obstetric, and gynecologic history were collected, including prior testosterone use, cervical cancer screening status, and preoperative pelvic imaging. Surgical pathologic findings of the endometrium, ovaries, and cervix were collected. RESULTS: A total of 72 individuals were included. The median age was 30 years (range 19-51). The majority of patients had private insurance (n=53, 74%) and were on testosterone at time of the preoperative visit (n=63, 88%). Forty-two patients (58%) reported anxiety, depression, or bipolar disorder, and 34 patients (47%) were taking an antidepressant or mood stabilizer. Of the 68 patients eligible for cervical cancer screening, 33 (49%) were up to date before their surgical consultation visits. Pelvic pain was the leading indication for surgery (n=65, 90%), and 29 patients (40%) had multiple listed indications for surgery. Surgical pathology results included cervical intraepithelial neoplasia 2-3 in three patients (4%), endometrial or cervical atrophy in 13 patients (18%), and ovarian or paratubal cysts in 16 patients (22%). CONCLUSION: This study describes the distinct clinical characteristics and surgical pathology findings that health care professionals should consider when caring for this unique patient population, including a relatively high rate of mental health conditions, pelvic pain as the leading indication for surgery, and the presence of endometrial or cervical atrophy and ovarian or paratubal cysts on surgical pathology.
引用
收藏
页码:51 / 57
页数:7
相关论文
共 25 条
  • [11] Feasibility of Vaginal Hysterectomy for Female-to-Male Transgender Men
    Obedin-Maliver, Juno
    Light, Alexis
    de Haan, Gene
    Jackson, Rebecca A.
    [J]. OBSTETRICS AND GYNECOLOGY, 2017, 129 (03) : 457 - 463
  • [12] Long-Term Mortality Associated With Oophorectomy Compared With Ovarian Conservation in the Nurses' Health Study
    Parker, William H.
    Feskanich, Diane
    Broder, Michael S.
    Chang, Eunice
    Shoupe, Donna
    Farquhar, Cynthia M.
    Berek, Jonathan S.
    Manson, JoAnn E.
    [J]. OBSTETRICS AND GYNECOLOGY, 2013, 121 (04) : 709 - 716
  • [13] Ovarian Conservation at the Time of Hysterectomy and Long-Term Health Outcomes in the Nurses' Health Study
    Parker, William H.
    Broder, Michael S.
    Chang, Eunice
    Feskanich, Diane
    Farquhar, Cindy
    Liu, Zhimae
    Shoupe, Donna
    Berek, Jonathan S.
    Hankinson, Susan
    Manson, JoAnn E.
    [J]. OBSTETRICS AND GYNECOLOGY, 2009, 113 (05) : 1027 - 1037
  • [14] Pap Test Use Is Lower Among Female-to-Male Patients Than Non-Transgender Women
    Peitzmeier, Sarah M.
    Khullar, Karishma
    Reisner, Sari L.
    Potter, Jennifer
    [J]. AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2014, 47 (06) : 808 - 812
  • [15] Female-to-Male Patients Have High Prevalence of Unsatisfactory Paps Compared to Non-Transgender Females: Implications for Cervical Cancer Screening
    Peitzmeier, Sarah M.
    Reisner, Sari L.
    Harigopal, Padmini
    Potter, Jennifer
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2014, 29 (05) : 778 - 784
  • [16] 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors
    Perkins, Rebecca B.
    Guido, Richard S.
    Castle, Philip E.
    Chelmow, David
    Einstein, Mark H.
    Garcia, Francisco
    Huh, Warner K.
    Kim, Jane J.
    Moscicki, Anna-Barbara
    Nayar, Ritu
    Saraiya, Mona
    Sawaya, George F.
    Wentzensen, Nicolas
    Schiffman, Mark
    [J]. JOURNAL OF LOWER GENITAL TRACT DISEASE, 2020, 24 (02) : 102 - 131
  • [17] Cervical Cancer Screening for Patients on the Female-to-Male Spectrum: a Narrative Review and Guide for Clinicians
    Potter, Jennifer
    Peitzmeier, Sarah M.
    Bernstein, Ida
    Reisner, Sari L.
    Alizaga, Natalie M.
    Agenor, Madina
    Pardee, Dana J.
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2015, 30 (12) : 1857 - 1864
  • [18] Barriers to Evidence-Based Transgender Care Knowledge Gaps in Gender-Affirming Hysterectomy and Oophorectomy
    Reilly, Zachary P.
    Fruhauf, Timothee F.
    Martin, Stephen J.
    [J]. OBSTETRICS AND GYNECOLOGY, 2019, 134 (04) : 714 - 717
  • [19] High risk and low uptake of pre-exposure prophylaxis to prevent HIV acquisition in a national online sample of transgender men who have sex with men in the United States
    Reisner, Sari L.
    Moore, Chiara S.
    Asquith, Andrew
    Pardee, Dana J.
    Sarvet, Aaron
    Mayer, Gal
    Mayer, Kenneth H.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2019, 22 (09)
  • [20] Test performance and acceptability of self-versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients
    Reisner, Sari L.
    Deutsch, Madeline B.
    Peitzmeier, Sarah M.
    Hughto, Jaclyn M. White
    Cavanaugh, Timothy P.
    Pardee, Dana J.
    McLean, Sarah A.
    Panther, Lori A.
    Gelman, Marcy
    Mimiaga, Matthew J.
    Potter, Jennifer E.
    [J]. PLOS ONE, 2018, 13 (03):